GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)
GoodRx Holdings recorded quarterly Non-Current Deferred Tax Liability of $650000.0 in Q3 2022, up 42.86% quarter-over-quarter from $455000.0 in Q2 2022.
GoodRx Holdings' Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $650000.0 for Q3 2022.
- In Q3 2022, Non-Current Deferred Tax Liability changed N/A year-over-year to $650000.0; the TTM figure through Sep 2022 stood at $650000.0 (changed N/A YoY), while the FY2021 annual figure was $244000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability came in at $650000.0 for Q3 2022 at GoodRx Holdings, up from $455000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q3 2020 to a low of $244000.0 in Q4 2021.
- A 3-year average of $703600.0 and a median of $455000.0 in 2022 frame the typical range for Non-Current Deferred Tax Liability.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 650,000.00 |
| Sep 30, 2022 | 650,000.00 |
| Jun 30, 2022 | 455,000.00 |
| Jun 30, 2022 | 455,000.00 |
| Mar 31, 2022 | 397,000.00 |
| Mar 31, 2022 | 397,000.00 |
| Dec 31, 2021 | 244,000.00 |
| Dec 31, 2021 | 244,000.00 |
| Sep 30, 2020 | 1.77 Mn |
| Sep 30, 2020 | 1.77 Mn |